ArticleFrontiers in neurology2025
Efficacy of acupuncture for chronic migraine: a protocol for a multicenter randomized controlled trial.
Article in Frontiers in neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Chronic migraine (CM) is a prevalent neurovascular disorder that significantly affects quality of life. Research has shown promising results for the efficacy of acupuncture in the treatment of chronic migraine. This study aims to evaluate the efficacy of acupuncture as a prophylactic treatment for chronic migraine through a multicenter randomized controlled trial. Materials and methods: This investigation constitutes a prospective, two-arm, multicenter randomized controlled trial involving a total of 180 patients diagnosed with chronic migraine (CM). Participants will be allocated in a 2:1 ratio to either the treatment group, receiving acupuncture, or the control group, receiving sham acupuncture. The intervention will be administered three times per week over a 6-week treatment period, followed by an 8-week follow-up phase. The primary outcome measure is the change from baseline in the average number of monthly headache days during weeks 3-6 of the treatment period. Secondary outcomes include changes in monthly headache days during follow-up, acute medication use days (AMDs), Migraine-Specific Quality of Life (MSQ), headache symptom scores, and pain severity as assessed using the visual analog scale (VAS). Ethics and dissemination: The study was approved by the Ethics Committee of Shandong University of Traditional Chinese Medicine (approval number: 2024-014-01-KY) and is registered with the Chinese Clinical Trial Registry (registration number: ChiCTR2400084720). Written informed consent was obtained from all participants. The results will be disseminated through peer-reviewed publications and conference presentations. Clinical trial registration: https://www.chictr.org.cn/showproj.html?proj=226947, identifier ChiCTR2400084720.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.